AstraZeneca Pharma India Ltd.’s Board of Directors has recommended a substantial final dividend of ₹24 per equity share for the financial year 2023–24. This decision was announced at the company’s board meeting held on May 27, 2024, where the audited financial results for the quarter and year ending March 31, 2024, were also approved.
Financial Performance
The audited financial results, along with the statutory auditors’ report dated May 27, 2024, were enclosed in the company’s exchange filing. AstraZeneca Pharma India Ltd. continues to demonstrate strong financial performance, as evidenced by the significant dividend recommendation.
Dividend Announcement
The proposed final dividend of ₹24 per equity share represents a significant payout to shareholders. For the financial year ending March 2023, the company had declared an equity dividend of 800%, amounting to ₹16 per share. The latest recommendation marks a continued commitment to rewarding shareholders.
Dividend History
AstraZeneca Pharma India has maintained a robust track record of dividend declarations over the past five years, reflecting consistent financial health and shareholder value creation. Below is a summary of the company’s recent dividend history:
| Date | Ex-date | Dividend Type | Dividend % | Amount |
|---|---|---|---|---|
| 30-05-2023 | 14-07-2023 | Final | 800 | 16 |
| 26-05-2022 | 07-07-2022 | Final | 400 | 8 |
| 09-08-2021 | 18-08-2021 | Interim | 100 | 2 |
| 10-08-2020 | 20-08-2020 | Interim | 100 | 2 |
| 07-08-2019 | 20-08-2019 | Interim | 50 | 1 |
Conclusion
The consistent dividend payouts by AstraZeneca Pharma India Ltd. underscore the company’s solid financial foundation and its commitment to shareholder returns. The recommendation of a ₹24 final dividend for FY 2023–24 is a testament to the company’s ongoing success and strategic financial management.
For comprehensive coverage of legal developments, business news, and real-time updates on law and politics, visit Kanishk Social Media.
If you like this story, share it with a friend!
Keywords: Tesla stock, Q4 delivery miss, TSLA, yearly sales decline, electric vehicles, Tesla deliveries, stock…
Keywords: Supreme Court, CJI Sanjiv Khanna, new year 2025, winter vacation, urgent listing, email system,…
Keywords: Indian youth, climate change, environment, climate impact survey, environmental awareness, India climate crisis, youth…
Keywords: industrial emissions, energy efficiency, decarbonisation, manufacturing sector, greenhouse gas emissions, fuel combustion, global warming,…
Keywords: Chennai Court, death sentence, Sathya murder case, stalking, IPC 302, Mahila Court, CB-CID, victim…
Keywords: 2024 hottest year, WMO report, climate change, dangerous heat, global warming, human health risks,…